Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1985 1
1986 3
1987 2
1988 4
1989 2
1990 1
1991 5
1992 1
1993 3
1994 1
1995 2
1997 4
1999 2
2000 2
2003 1
2005 1
2006 1
2007 5
2008 3
2009 3
2010 3
2011 2
2012 2
2013 2
2014 3
2015 4
2016 1
2017 2
2018 2
2020 2
2021 5
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
Controversies in the management of gastrointestinal stromal tumors.
Yip D, Zalcberg J, Ackland S, Barbour AP, Desai J, Fox S, Kotasek D, McArthur G, Smithers BM. Yip D, et al. Among authors: kotasek d. Asia Pac J Clin Oncol. 2014 Sep;10(3):216-27. doi: 10.1111/ajco.12187. Epub 2014 Mar 27. Asia Pac J Clin Oncol. 2014. PMID: 24673914 Review.
The hypereosinophilic syndrome.
Purdie GH, Kotasek D, Rischbieth RH. Purdie GH, et al. Among authors: kotasek d. Clin Exp Neurol. 1983;19:60-6. Clin Exp Neurol. 1983. PMID: 6096051
Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study.
Tie J, Wang Y, Cohen J, Li L, Hong W, Christie M, Wong HL, Kosmider S, Wong R, Thomson B, Choi J, Fox A, Field K, Burge M, Shannon J, Kotasek D, Tebbutt NC, Karapetis C, Underhill C, Haydon A, Schaeffer J, Ptak J, Tomasetti C, Papadopoulos N, Kinzler KW, Vogelstein B, Gibbs P. Tie J, et al. Among authors: kotasek d. PLoS Med. 2021 May 3;18(5):e1003620. doi: 10.1371/journal.pmed.1003620. eCollection 2021 May. PLoS Med. 2021. PMID: 33939694 Free PMC article.
Lead poisoning--a family study.
Parnis FX, Kotasek D, Sage RE. Parnis FX, et al. Among authors: kotasek d. Med J Aust. 1991 Dec 2-16;155(11-12):750-2. doi: 10.5694/j.1326-5377.1991.tb94026.x. Med J Aust. 1991. PMID: 1745163
A first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer.
Day D, Park JJ, Coward J, Markman B, Lemech C, Kuo JC, Prawira A, Brown MP, Bishnoi S, Kotasek D, Strother RM, Cosman R, Su R, Ma Y, Yue Z, Hu HH, Wu R, Li P, Tse AN. Day D, et al. Among authors: kotasek d. Br J Cancer. 2023 Nov;129(10):1608-1618. doi: 10.1038/s41416-023-02431-7. Epub 2023 Sep 20. Br J Cancer. 2023. PMID: 37731023 Free PMC article. Clinical Trial.
Anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody quavonlimab in combination with pembrolizumab: Safety and efficacy from a phase I study in previously treated extensive-stage small cell lung cancer.
Cho BC, Yoh K, Perets R, Nagrial A, Spigel DR, Gutierrez M, Kim DW, Kotasek D, Rasco D, Niu J, Satouchi M, Ahn MJ, Lee DH, Maurice-Dror C, Siddiqi S, Ren Y, Altura RA, Bar J. Cho BC, et al. Among authors: kotasek d. Lung Cancer. 2021 Sep;159:162-170. doi: 10.1016/j.lungcan.2021.07.009. Epub 2021 Jul 18. Lung Cancer. 2021. PMID: 34371366 Free article. Clinical Trial.
Safety and efficacy of quavonlimab, a novel anti-CTLA-4 antibody (MK-1308), in combination with pembrolizumab in first-line advanced non-small-cell lung cancer.
Perets R, Bar J, Rasco DW, Ahn MJ, Yoh K, Kim DW, Nagrial A, Satouchi M, Lee DH, Spigel DR, Kotasek D, Gutierrez M, Niu J, Siddiqi S, Li X, Cyrus J, Chackerian A, Chain A, Altura RA, Cho BC. Perets R, et al. Among authors: kotasek d. Ann Oncol. 2021 Mar;32(3):395-403. doi: 10.1016/j.annonc.2020.11.020. Epub 2020 Dec 2. Ann Oncol. 2021. PMID: 33276076 Free article. Clinical Trial.
Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)☆.
Casali PG, Le Cesne A, Velasco AP, Kotasek D, Rutkowski P, Hohenberger P, Fumagalli E, Judson IR, Italiano A, Gelderblom H, Penel N, Hartmann JT, Duffaud F, Goldstein D, Martin-Broto J, Gronchi A, Wardelmann E, Marréaud S, Zalcberg JR, Litière S, Blay JY. Casali PG, et al. Among authors: kotasek d. Ann Oncol. 2021 Apr;32(4):533-541. doi: 10.1016/j.annonc.2021.01.004. Epub 2021 Jan 19. Ann Oncol. 2021. PMID: 33482247 Free article. Clinical Trial.
Herpes simplex virus-infected cells disarm killer lymphocytes.
Confer DL, Vercellotti GM, Kotasek D, Goodman JL, Ochoa A, Jacob HS. Confer DL, et al. Among authors: kotasek d. Proc Natl Acad Sci U S A. 1990 May;87(9):3609-13. doi: 10.1073/pnas.87.9.3609. Proc Natl Acad Sci U S A. 1990. PMID: 2159156 Free PMC article.
73 results